rofecoxib has been researched along with Skin Diseases in 3 studies
Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A tolerance observed to this drug during SBPCOCs will indicate a safe alternative in this patient-group." | 2.70 | Safety of selective cyclooxygenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions. ( Florido, JJ; Quiralte, J; Sáenz de San Pedro, B, 2002) |
| "Rofecoxib is a safe alternative in subjects with previous adverse cutaneous reaction to NSAIDs." | 2.70 | Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs. ( Barbagallo, M; Biasi, D; Corrocher, R; Di Lorenzo, G; Pacor, ML, 2002) |
| "Rofecoxib is a novel NSAID which selectively inhibits prostaglandin endoperoxide H synthase-2 and has no effect on prostaglandin endoperoxide H synthase-1." | 1.31 | Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugs. ( Di, PR; Ferrannini, A; Nettis, E; Tursi, A, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quiralte, J | 1 |
| Sáenz de San Pedro, B | 1 |
| Florido, JJ | 1 |
| Nettis, E | 1 |
| Di, PR | 1 |
| Ferrannini, A | 1 |
| Tursi, A | 1 |
| Pacor, ML | 1 |
| Di Lorenzo, G | 1 |
| Biasi, D | 1 |
| Barbagallo, M | 1 |
| Corrocher, R | 1 |
2 trials available for rofecoxib and Skin Diseases
| Article | Year |
|---|---|
Safety of selective cyclooxygenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhib | 2002 |
Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Double-Blind Met | 2002 |
1 other study available for rofecoxib and Skin Diseases
| Article | Year |
|---|---|
Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugs.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Drug Hypersensit | 2002 |